Acquisition by Ra Capital Management, L.p. of 2557593 shares of PepGen at 10.64 subject to Rule 16b-3
PEPG Stock | USD 5.10 0.32 6.69% |
Roughly 54% of PepGen's investor base is interested to short. The analysis of the overall investor sentiment regarding PepGen suggests that many traders are impartial. The current market sentiment, together with PepGen's historical and current headlines, can help investors time the market. In addition, many technical investors use PepGen stock news signals to limit their universe of possible portfolio assets.
PepGen |
Filed transaction by PepGen Director, 10 Percent Owner: . Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at finance.yahoo.com
PepGen Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards PepGen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
PepGen Fundamental Analysis
We analyze PepGen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PepGen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PepGen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
PepGen is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
PepGen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PepGen stock to make a market-neutral strategy. Peer analysis of PepGen could also be used in its relative valuation, which is a method of valuing PepGen by comparing valuation metrics with similar companies.
Peers
PepGen Related Equities
IPSC | Century Therapeutics | 20.74 | ||||
PRTC | PureTech Health | 10.12 | ||||
CCCC | C4 Therapeutics | 8.59 | ||||
MLYS | Mineralys Therapeutics, | 4.71 | ||||
VIGL | Vigil Neuroscience | 4.55 | ||||
CMPX | Compass Therapeutics | 3.31 | ||||
MOLN | Molecular Partners | 3.19 | ||||
CGEM | Cullinan Oncology | 2.51 | ||||
TRDA | Entrada Therapeutics | 2.37 | ||||
RLYB | Rallybio Corp | 1.85 | ||||
TYRA | Tyra Biosciences | 1.78 | ||||
PMVP | Pmv Pharmaceuticals | 0.63 | ||||
EWTX | Edgewise Therapeutics | 0.37 | ||||
ELYM | Eliem Therapeutics | 1.30 | ||||
ANTX | AN2 Therapeutics | 1.44 | ||||
MNOV | MediciNova | 3.37 | ||||
PHVS | Pharvaris | 7.49 |
Complementary Tools for PepGen Stock analysis
When running PepGen's price analysis, check to measure PepGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PepGen is operating at the current time. Most of PepGen's value examination focuses on studying past and present price action to predict the probability of PepGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PepGen's price. Additionally, you may evaluate how the addition of PepGen to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |